$5.73
-0.05-0.87%
At Close: -
$5.73
00.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Comments
Loading...
Inozyme Pharma (INZY) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInozyme Pharma (NASDAQ:INZY) Stock Quotes, Forecast and News Summary
Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.
| Open | $5.72 |
| Close | $5.73 |
| Volume / Avg. | 426.00K / 304.18K |
| Day Range | $5.61 - $5.78 |
| 52 Wk Range | 2.69 - 7.80 |
| Market Cap | $384.48M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 60 |
| Short Interest | 6.4% |
| Days to Cover | 10.55 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Inozyme Pharma Inc
Sector
Health Care
Industry
Biotechnology
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutic...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inozyme Pharma (INZY) stock?
You can purchase shares of Inozyme Pharma (NASDAQ:INZY) through any online brokerage.
Who are Inozyme Pharma (INZY) competitors?
Other companies in Inozyme Pharma’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR) and Fate Therapeutics (NASDAQ:FATE).
What is the forecast, or price target, for Inozyme Pharma (INZY) stock?
Inozyme Pharma has a consensus price target of $14.88.
What is the current price for Inozyme Pharma (INZY)?
The stock price for Inozyme Pharma (NASDAQ: INZY) is $5.73 last updated September 20, 2024 at 4:04 PM EDT.
Does Inozyme Pharma (INZY) pay a dividend?
There are no upcoming dividends for Inozyme Pharma.
When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?
Inozyme Pharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Inozyme Pharma (INZY) going to split?
There is no upcoming split for Inozyme Pharma.
What sector and industry does Inozyme Pharma (INZY) operate in?
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.